• Publications
  • Influence
Invasive methicillin-resistant Staphylococcus aureus infections in the United States.
CONTEXT As the epidemiology of infections with methicillin-resistant Staphylococcus aureus (MRSA) changes, accurate information on the scope and magnitude of MRSA infections in the US population isExpand
  • 3,370
  • 144
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.
CONTEXT Group B streptococcus is a leading infectious cause of morbidity in newborns and causes substantial disease in elderly individuals. Guidelines for prevention of perinatal disease throughExpand
  • 606
  • 44
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.
CONTEXT Pneumococcal polysaccharide vaccine is recommended for elderly persons and adults with certain chronic illnesses. Additionally, a recently licensed pneumococcal 7-valent conjugate vaccine hasExpand
  • 656
  • 35
Bacterial meningitis in the United States, 1998-2007.
BACKGROUND The rate of bacterial meningitis declined by 55% in the United States in the early 1990s, when the Haemophilus influenzae type b (Hib) conjugate vaccine for infants was introduced. MoreExpand
  • 621
  • 35
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.
BACKGROUND In 2000, seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the USA and resulted in dramatic reductions in invasive pneumococcal disease (IPD) and moderate increases inExpand
  • 432
  • 29
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.
BACKGROUND Guidelines issued in 1996 in the United States recommend either screening of pregnant women for group B streptococcal colonization by means of cultures (screening approach) or assessingExpand
  • 537
  • 27
Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007.
BACKGROUND Group B Streptococcus (GBS), traditionally considered to be a neonatal pathogen, is an important cause of morbidity and mortality among older adults and among those with underlying medicalExpand
  • 305
  • 26
Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.
Severe invasive group A streptococcal (GAS) disease is believed to have reemerged during the past 10-20 years. We conducted active, laboratory, population-based surveillance in 5 US states (totalExpand
  • 325
  • 25
Active bacterial core surveillance of the emerging infections program network.
Active Bacterial Core surveillance (ABCs) is a collaboration between the Centers for Disease Control and Prevention and several state health departments and universities participating in the EmergingExpand
  • 640
  • 23
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
BACKGROUND The emergence of drug-resistant strains of bacteria has complicated treatment decisions and may lead to treatment failures. METHODS We examined data on invasive pneumococcal disease inExpand
  • 885
  • 22